Related Experiment Video
Updated: May 1, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
The 3-NP Model of Striatal Neurodegeneration
1Neurodegenerative Diseases Laboratory, URA2210, CEA, and CNRS, Molecular Imaging Research Center (MIRCen), I2BM, Life Science Division, Fontenay-aux-Roses, France.
Abstract:
The mitochondrial toxin 3-nitropropionic acid (3-NP) is an irreversible inhibitor of respiratory chain complex II. Chronic systemic administration of 3-NP to mice, rats, and non-human primates leads to preferential degeneration of the striatum, and produces motor and cognitive symptoms that are highly reminiscent of Huntington's disease (HD). HD is caused by a dominant inherited expansion of CAG repeats in the Huntington gene. Thus, many aspects of HD cannot be mimicked by 3-NP. However, recent research shows that mitochondrial defects and oxidative stress may play a key role in HD pathogenesis, further supporting the potential utility of the 3-NP model of striatal degeneration. First, a basic protocol to produce acute striatal lesions in rats using repeated intraperitoneal injection of 3-NP is described. Second, a more complex protocol that takes advantage of the use of osmotic minipumps to steadily release 3-NP leading to consistent lesions and motor symptoms in Lewis rats is presented.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Alzheimer Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Dementia l: Introduction

